Steven J. Rice - 17 Feb 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Chief Administrative Officer
Signature
/s/ Howard Horn, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
17 Feb 2023
Net transactions value
-$50,096
Form type
4
Filing time
21 Feb 2023, 18:25:01 UTC
Previous filing
24 Feb 2022
Next filing
24 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Sale $50,096 -1,981 -5.1% $25.29 37,209 17 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
F2 Includes 532 shares of common stock acquired by the reporting person on May 31, 2022 pursuant to an employee stock purchase program.